Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wass

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
British Medical Journal (Clinical Research Ed.)|June 16, 1984
Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapyA Grossman, N Lytras, M O Savage, et al.
Clinical Endocrinology|June 1, 1980
Circulating somatostatin after food and glucose in manJ A Wass, E Penman, J R Dryburgh, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
British Journal of Urology|December 1, 1983
Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormoneJ H Waxman, J A Wass, W F Hendry, et al.
Clinical Endocrinology|February 1, 1990
The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabeticsA M Taylor, D B Dunger, M A Preece, et al.
Clinical Endocrinology|June 1, 1991
The presence of cation-dependent proteases for insulin-like growth factor binding proteins does not alter the size distribution of insulin-like growth factors in pregnancyS C Davies, J M Holly, V J Coulson, et al.
Gut|February 1, 1993
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegalyS M Catnach, J V Anderson, P D Fairclough, et al.
Carcinogenesis|November 8, 2001
Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomasD J Simpson, A A Fryer, A B Grossman, et al.
Clinical Endocrinology|January 1, 1984
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitaryN Lytras, A Grossman, L Perry, et al.
Clinical Endocrinology|August 1, 1991
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeJ A Verhelst, P J Trainer, T A Howlett, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
British Medical Journal (Clinical Research Ed.)|June 16, 1984
Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapyA Grossman, N Lytras, M O Savage, et al.
Clinical Endocrinology|June 1, 1980
Circulating somatostatin after food and glucose in manJ A Wass, E Penman, J R Dryburgh, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
British Journal of Urology|December 1, 1983
Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormoneJ H Waxman, J A Wass, W F Hendry, et al.
Clinical Endocrinology|February 1, 1990
The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabeticsA M Taylor, D B Dunger, M A Preece, et al.
Clinical Endocrinology|June 1, 1991
The presence of cation-dependent proteases for insulin-like growth factor binding proteins does not alter the size distribution of insulin-like growth factors in pregnancyS C Davies, J M Holly, V J Coulson, et al.
Gut|February 1, 1993
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegalyS M Catnach, J V Anderson, P D Fairclough, et al.
Carcinogenesis|November 8, 2001
Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomasD J Simpson, A A Fryer, A B Grossman, et al.
Clinical Endocrinology|January 1, 1984
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitaryN Lytras, A Grossman, L Perry, et al.
Clinical Endocrinology|August 1, 1991
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeJ A Verhelst, P J Trainer, T A Howlett, et al.
Pageof 25